$CADL
Candel Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$10.75
▼-5.20%-$0.590
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCandel Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CADL down today? It is at $10.75 (-5.20%), and our scanner flagged it 73 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CADL spikes, and full due diligence on CADL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CADL 73 times in the last 30 days. Create a free account to track $CADL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CADL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CADL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Tak Paul Peter Officer | Sold (automatic/other) | -59K 0.08% of company | sold 34% | 113K | $621K at $10.46 | Sep 11, 26 |
Tak Paul Peter Officer | Sold (automatic/other) | -221K 0.3% of company | sold 56% | 173K | $2.5M at $11.50 | Sep 10, 26 |
Tak Paul Peter Officer | Other | 125K 0.2% of company | added 47% | 394K | $194K at $1.55 | Sep 10, 26 |
Tyagarajan Seshu Officer | Sold (automatic/other) | -7K | sold 8.3% | 77K | $84K at $12.00 | Aug 17, 26 |
Tyagarajan Seshu Officer | Sold (automatic/other) | -7K | sold 7.7% | 84K | $70K at $10.02 | Jun 29, 26 |
Barone Francesca Officer | Sold (automatic/other) | -23K 0.03% of company | sold 23% | 77K | $236K at $10.06 | Jun 29, 26 |
Manning Paul B Director | Bought (open market) | +550K 0.7% of company | added 16% | 4.07M | $3.0M at $5.45 | Feb 23, 26 |
Nichols William Garrett Officer | Sold (automatic/other) | -937 | sold 1.8% | 52K | $7K at $6.98 | Jul 28, 25 |
Nichols William Garrett Officer | Other | 937 | added 1.8% | 53K | $1K at $1.29 | Jul 28, 25 |
Nichols William Garrett Officer | Sold (automatic/other) | -781 | sold 1.5% | 52K | $4K at $5.04 | Jun 30, 25 |
Nichols William Garrett Officer | Other | 781 | added 1.5% | 53K | $1K at $1.29 | Jun 30, 25 |
Martell Christopher Director | Acquired (grant/award) | +111K 0.1% of company | added 26% | 547K | $520K at $4.67 | Jun 25, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CADL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CADL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CADL last traded at $10.75, down 5.20% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Candel Therapeutics, Inc. Common Stock (CADL) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CADL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CADL 73 times in the last 30 days.
CADL (Candel Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $830M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CADL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CADL discussion
Sign in to ask a question or join the discussion.